Presentation
I am a researcher at Kela’s Research Unit. My area of research concerns the extensions to indications for new outpatient cancer medicines. I also work as a health economics expert, giving opinions on pharmaceuticals pricing and reimbursement.
Expertise
- health economics
Ongoing research projects
Publications and research projects
21.10.2024
New Cancer Medicines in Europe 2010-2020: Comparison of Medicines With or Without Extensions of Indications
The lifecycle of cancer medicines and especially the role and level of evidence extensions in comparison to first indications.
1.1.2021
New Outpatient Cancer Medicines: Reimbursement and Uptake
The project produces research data in the field of new outpatient cancer medicines.
Other researchers
Share this article
